MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes
Journal Article

Glycemia Reduction in Type 2 Diabetes — Microvascular and Cardiovascular Outcomes

2022
Request Book From Autostore and Choose the Collection Method
Overview
In a secondary analysis comparing the effect of insulin glargine, glimepiride, liraglutide, and sitagliptin, added to metformin, on the incidences of microvascular complications and death, no material between-group differences were seen.
Publisher
Massachusetts Medical Society
Subject

Albuminuria - etiology

/ Albuminuria - prevention & control

/ Antidiabetics

/ Blood glucose

/ Blood Glucose - analysis

/ Blood pressure

/ Cardiology

/ Cardiology General

/ Cardiovascular disease

/ Cardiovascular diseases

/ Cardiovascular Diseases - etiology

/ Cardiovascular Diseases - prevention & control

/ Chronic Kidney Disease

/ Clinical Medicine

/ Clinical trials

/ Comparative Effectiveness Research

/ Congestive heart failure

/ Creatinine

/ Death

/ Diabetes

/ Diabetes Complications - etiology

/ Diabetes Complications - prevention & control

/ Diabetes mellitus (non-insulin dependent)

/ Diabetes Mellitus, Type 2 - complications

/ Diabetes Mellitus, Type 2 - drug therapy

/ Diabetic Neuropathies - diagnosis

/ Diabetic Neuropathies - etiology

/ Diabetic Neuropathies - prevention & control

/ Drug Therapy, Combination

/ Dyslipidemia

/ Dyslipidemias - etiology

/ Dyslipidemias - prevention & control

/ Endocrinology

/ FDA approval

/ Glomerular Filtration Rate

/ Glucose

/ Glycated Hemoglobin - analysis

/ Heart Failure - etiology

/ Heart Failure - prevention & control

/ Hemoglobin

/ Humans

/ Hypertension

/ Hypertension - etiology

/ Hypertension - prevention & control

/ Hypoglycemia

/ Hypoglycemic Agents - adverse effects

/ Hypoglycemic Agents - therapeutic use

/ Insulin

/ Insulin Glargine - adverse effects

/ Insulin Glargine - therapeutic use

/ Kidney diseases

/ Liraglutide - adverse effects

/ Liraglutide - therapeutic use

/ Metabolism

/ Metformin

/ Metformin - adverse effects

/ Metformin - therapeutic use

/ Microvasculature

/ Microvessels - drug effects

/ Nephrology

/ Outpatient-Based Clinical Medicine

/ Peripheral neuropathy

/ Risk factors

/ Sitagliptin Phosphate - adverse effects

/ Sitagliptin Phosphate - therapeutic use

/ Sulfonylurea Compounds - adverse effects

/ Sulfonylurea Compounds - therapeutic use